# The Efficacy and Safety of Utidelone Plus Tirelizumab and Bevacizumab for Advanced or Metastatic Triple-negative Breast Cancer (UTILIZABLE) ：Single-arm, Prospec

Source: https://onco.cc/trials/nct06125080/  
OnCo record `nct06125080` (Trial). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)"; commercial use needs a licence.

## TL;DR

A phase 2 trial of utidelone and bevacizumab in triple-negative breast cancer, run by Huihua Xiong, now recruiting.

## Summary

The Efficacy and Safety of Utidelone Plus Tirelizumab and Bevacizumab for Advanced or Metastatic Triple-negative Breast Cancer (UTILIZABLE) ：Single-arm, Prospective, Open Clinical Study is a phase 2, interventional study registered as NCT06125080 by Huihua Xiong, with a registry enrolment figure of 78 participants, started 2023-10-30 and due to reach its primary completion in 2025-10-30. Interventions recorded: Utidelone; Tirelizumab; Bevacizumab. Conditions listed: TNBC - Triple-Negative Breast Cancer. Triple-negative eligibility wording from the registry: "Patients voluntarily participated in the study, signed the informed consent, and had good compliance; Female patients aged 18-70; TNBC confirmed by histology or cytology". Sites: China. No results are recorded here; the registry entry is the source.

## Fields

- Kind: Trial
- Status: recruiting
- Last checked: 2026-09-24
- Also known as: UTILIZABLE
- Tags: ctgov-ingest; tnbc-deep-dive
- Registry id: NCT06125080
- Phase: 2
- Setting: The Efficacy and Safety of Utidelone Plus Tirelizumab and Bevacizumab for Advanced or Metastatic Triple-negative Breast Cancer (UTILIZABLE) ：Single-arm, Prospective, Open Clinical Study
- Sponsor: Huihua Xiong
- Enrolled: 78

## Sources

- ClinicalTrials.gov NCT06125080: https://clinicaltrials.gov/study/NCT06125080

## Connected records

- cancers: [Metastatic triple-negative breast cancer](https://onco.cc/cancers/tnbc-metastatic/)
- technologies: [Cytotoxic chemotherapy](https://onco.cc/technologies/cytotoxic-chemotherapy/)
- drugs: [Bevacizumab](https://onco.cc/drugs/bevacizumab/), [Utidelone](https://onco.cc/drugs/utidelone/)
- terms: [Triple-negative breast cancer trials open today (registry snapshot and UK sites)](https://onco.cc/terms/tnbc-trials-open-today/)

---
JSON: https://onco.cc/api/v1/entities/nct06125080.json